Glimanthro-M1 1/500 Tablet PR
Marketer
Silantro Pharma Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimanthro-M1 1/500 Tablet PR
Diabetic patients using the anti-diabetic medication, Glimanthro-M1 1/500 Tablet PR (a dual-medicine formulation), should adhere to prescribed dosage and timing, consistently taken with meals. Dosage adjustments are determined by individual response and blood glucose monitoring, as directed by the physician. Continuous use is crucial for effective blood sugar management; premature discontinuation can lead to dangerously elevated blood sugar, potentially resulting in kidney complications, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan, incorporating diet, exercise, and weight control as advised by your doctor. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and trembling. Regular meals, readily available glucose sources (e.g., sugary foods or juice), and alcohol avoidance are essential for prevention. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, upper respiratory infections, and weight gain. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Patients with a history of heart disease, pregnant women, and breastfeeding mothers should consult their doctor before commencing treatment. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are necessary.
Uses of Glimanthro-M1 1/500 Tablet PR
Managing type 2 diabetes
Major Benefits of Glimanthro-M1 1/500 Tablet PR:
Follow your physician's instructions or consult the product labeling for proper administration. Ingest Glimanthro-M1 1/500 Tablet PR with a meal.
Common Side effects of Glimanthro-M1 1/500 Tablet PR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimanthro-M1 1/500 Tablet PR:
Follow your physician's guidance or consult the product information leaflet for usage instructions. Administer Glimanthro-M1 1/500 Tablet PR with a meal.
How Glimanthro-M1 1/500 Tablet PR works:
Glimanthro-M1 1/500 PR tablets contain a dual antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Glimanthro-M1 1/500 Tablet PR is contraindicated due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glimanthro-M1 1/500 Tablet PR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Using Glimanthro-M1 1/500 Tablet PR while breastfeeding is contraindicated due to the potential for infant toxicity. Evidence indicates the drug may harm the nursing infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Exercise caution when administering Glimanthro-M1 1/500 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. For patients exhibiting severe kidney disease, Glimanthro-M1 1/500 Tablet PR is contraindicated. Close monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimanthro-M1 1/500 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate hepatic dysfunction, initiation should involve a low Glimanthro-M1 1/500 Tablet PR dose; its administration is contraindicated in cases of severe liver disease.
What if you forget to take Glimanthro-M1 1/500 Tablet PR :
Should you forget a Glimanthro-M1 1/500 Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimanthro-M1 1/500 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



